{
    "clinical_study": {
        "@rank": "105839", 
        "arm_group": {
            "arm_group_label": "CACS and NIRS", 
            "arm_group_type": "Experimental", 
            "description": "All patients will undergo NIRS to at least 2 major epicardial vessels as a research related intervention.  Patients will be considered to be enrolled in the trial upon completion NIRS evaluation.  Patients who had a clinically indicated CT with CACS evaluation within 3 months prior to the cardiac catheterization with NIRS evaluation will not have any other research related interventions.  Patients who have not had a clinically indicated CT with CACS within 3 months prior to the cardiac catheterization with NIRS evaluation will have the CACS after NIRS imaging prior to discharge from the hospital."
        }, 
        "brief_summary": {
            "textblock": "The aim of this study is to compare the relationship between the coronary artery\n      calcification assessed by MDCT with the plaque characteristics and necrotic lipid core\n      content of non-intervened coronary segments assessed with near infrared spectroscopy (NIRS)\n      in patients with symptomatic coronary artery disease (CAD)."
        }, 
        "brief_title": "Atherosclerotic Coronary Vulnerable Plaque: Correlation With Coronary Artery Calcium", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "A total of 60 patients, from a single center, who meet all of the study inclusion criteria\n      and none of the study exclusion criteria will be prospectively enrolled in this study.\n      Qualifying patients will be referred to the study site for clinically indicated,\n      non-emergent cardiac catheterization with NIRS evaluation, either proceeded or followed by\n      coronary artery calcium score (CACS) evaluation.\n\n      Qualifying patients that are referred directly to cardiac catheterization with NIRS\n      assessment secondary to symptoms or abnormal functional test will be sent for cardiac CACS\n      assessment following the catheterization before discharge from the hospital. In this group,\n      patients who require ad hoc PCI upon initial angiography will be excluded to avoid artifacts\n      on  CACS.  In patients who are referred for a clinically indicated cardiac catheterization\n      with IVUS evaluation within 3 months after MDCT with CACS, NIRS of at least two (2) major\n      epicardial vessels will be completed prior to any (if necessary) coronary revascularization."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient is \u226518 years of age\n\n          -  Patient is clinically indicated due to angina, abnormal functional test or other\n             ischemic symptoms to undergo non-emergent cardiac catheterization with IVUS\n             evaluation i.If the patient has not had a cardiac MDCT with CACS meeting the protocol\n             requirements within 3 months prior to the cardiac catheterization, the patient is\n             able to undergo CACS following LipiScan IVUS and NIRS evaluation, prior to any\n             coronary revascularization ii. If the patient has had a cardiac MDCT evaluation with\n             CACS meeting the protocol requirements within 3 months prior to  the cardiac\n             catheterization,  LipiScan IVUS and NIRS imaging will be completed in at least two\n             (2) major epicardial vessels prior to any coronary revascularization\n\n          -  At least two (2) major epicardial native vessels are suitable for interrogation by\n             LipiScan IVUS imaging and NIRS evaluation, defined as:\n\n             i.At least 30 mm of vessel that is > 2.0mm in diameter ii.No other contraindications\n             to imaging\n\n          -  No contraindications for LipiScan IVUS and NIRS evaluation\n\n          -  No contraindications for CACS evaluation by MDCT\n\n          -  Subject must be able to provide informed consent form and comply with the protocol\n             requirements\n\n        Exclusion Criteria:\n\n          -  Evidence of clinical hemodynamic instability in the 6 hours before either procedure\n\n          -  Prior history of  percutaneous coronary intervention (PCI) with stent placement\n\n          -  Prior history of bypass grafts\n\n          -  Female subject that is pregnant or lactating\n\n          -  Any other factor that the investigator feels would put the patient at increased risk\n             or otherwise make the patient unsuitable for participation in the protocol"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01830062", 
            "org_study_id": "CACS NIRS"
        }, 
        "intervention": [
            {
                "arm_group_label": "CACS and NIRS", 
                "description": "Near infrared spectroscopy of at least 2 major epicardial vessels", 
                "intervention_name": "NIRS", 
                "intervention_type": "Other", 
                "other_name": "LipiScan Coronary Imaging System, InfraReDx, Inc."
            }, 
            {
                "arm_group_label": "CACS and NIRS", 
                "description": "Coronary artery calcium score assessed by multi-slice computed tomography", 
                "intervention_name": "CACS", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 31, 2013", 
        "location": {
            "contact": {
                "email": "ron.waksman@medstar.net", 
                "last_name": "Ron Waksman, MD", 
                "phone": "202-877-2812"
            }, 
            "facility": {
                "address": {
                    "city": "Washington", 
                    "country": "United States", 
                    "state": "District of Columbia", 
                    "zip": "20010"
                }, 
                "name": "MedStar Washington Hospital Center"
            }, 
            "investigator": {
                "last_name": "Ron Waksman, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Atherosclerotic Coronary Vulnerable Plaque: Correlation With Coronary Artery Calcium", 
        "overall_official": {
            "affiliation": "Medstar Washington Hospital Center", 
            "last_name": "Ron Waksman, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary endpoint for this study is individual patient level correlation between the total CACS of the entire coronary tree with the max LCBI4mm within the vessels imaged.", 
            "measure": "Correlation between CACS and LCBI", 
            "safety_issue": "No", 
            "time_frame": "maximum duration of 3 months between CACS and NIRS"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01830062"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Vessel level and individual coronary artery level (LM, LAD, LCx, RCA) analysis of CACS with max LCBI4mm and total LCBI for the vessel imaged", 
                "measure": "Vessel level correlation of CACS and LCBI", 
                "safety_issue": "No", 
                "time_frame": "maximum of 3 months between CACS and NIRS"
            }, 
            {
                "description": "Vessel level comparison of angiographic and IVUS parameters with yellow plaque defined by LCBI (both max LCBI4mm and total vessel LCBI)", 
                "measure": "Vessel level comparison of angiographic and IVUS parameters", 
                "safety_issue": "No", 
                "time_frame": "maximum of 3 months between CACS and NIRS"
            }, 
            {
                "description": "In subset of patient where coronary angiography and NIRS is driven by patient with abnormal CT coronary angiogram, the CT angiographic parameters are utilized for Segment level analysis between the CACS, IVUS and lipid core plaque", 
                "measure": "Segment level analysis of CACS, IVUS and lipid core plaque in patients with abnormal CT", 
                "safety_issue": "No", 
                "time_frame": "maximum of 3 months between CACS and NIRS"
            }
        ], 
        "source": "Medstar Research Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medstar Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}